Академический Документы
Профессиональный Документы
Культура Документы
presentationoutline
I. INTRODUCTION
Problem and its background Conceptual Framework Objective Statement of the Problem Hypothesis Significance of the Study Scope and Limitation II. METHODOLOGY III.RESULTS AND DISCUSSIONS IV.CONCLUSION and RECOMMENDATION
INTRODUCTION
Staphylococcus aureus an organism which can be found on human skin and frequently inhabits the nose, and less commonly the throat.
conceptual framework
INPUT (Literature search finding about Pine tree, Escherichia coli, and Staphylococcus aureus)
Plant collection Extraction Isolating pure cultures (streak plate technique) Agar well diffusion, MIC, MBC OUTPUT Pinus kesiya bark extract as an antimicrobial agent against E.coli and S. aureus
objective
MAIN OBJECTIVE
To determine if the Pinus kesiya bark extract has an antibacterial activity against Staphylococcus aureus and Escherichia coli.
objective
SPECIFIC OBJECTIVES
a. To determine if the active metabolites, tannins, flavonoids and terpenoids are present and can be isolated from the bark of the Pinus kesiya.
b. To determine if the isolated phytochemical compounds present in the crude extract of Pinus kesiya bark has an antibacterial activity against Staphylococcus aureus and Escherichia coli.
objective
SPECIFIC OBJECTIVES
c. To determine the lowest concentration of the extracts of Pinus kesiya bark that showed antibacterial activity against Staphylococcus aureus and Escherichia coli
d. To compare the antibacterial activity of the crude extract and the isolated compounds with the positive control.
objective
SPECIFIC OBJECTIVES
e. To determine if the crude extract and isolated compounds of Pinus kesiya bark has a bacteriostatic or bactericidal effect.
hypothesis
Ho: The Pinus kesiya bark extract has no antibacterial activity against Staphylococcus aureus and Escherichia coli.
HI: The Pinus kesiya bark extract has an antibacterial activity against Staphylococcus aureus and Escherichia coli.
The determination of compounds with antibacterial activity against clinically infectious strains of bacteria, while maximizing natural resources found in the Philippines
Would help decrease the economic burden of medications and the prevalence of diseases caused by the said organisms.
There are no previous studies about the antibacterial activity of Pinus kesiya bark. Thus, this study will give baseline information in the use of Pinus kesiya as an antibacterial agent.
Antibacterial activity of the bark extract of Pinus kesiya acquired from Baguio City
limited to crude extraction and isolation of three phytochemical compounds present in the bark
No further characterization of the collected plant material and quantification of the isolated compounds through any molecular method were done.
This study only determines the inhibitory effects of the extract against Escherichia coli and Staphylococcus aureus
No identification of the phytochemical compound that showed the greatest contribution in the antibacterial activity of the crude extract was done.
METHODOLOGY
PROCEDURE
Procedure
Plant collection and plant extraction
FLAVONOIDS
Assay
TERPENOIDS
Assay
MIC
MIC
MIC
MBC
MBC
MBC
Pinus kesiya bark crude extract and the isolated compounds are tested by using Agar-Well Method
plant material
Plant specimen verified and authenticated by Danilo N. Tandang of Department of Botany, National Museum
isolated compounds
1. Tannins 2. Flavonoids 3. Terpenoids
ISOLATED COMPOUNDS
TANNINS
400 grams of air-dried pine tree bark Isolated 2.7 grams (0.68%) of crude tannin
1 2
Qualitative test gave a blue-black color on Ferric Chloride test and definite precipitate in lead acetate test
ISOLATED COMPOUNDS
FLAVONOIDS
1 2 3.02 grams flavonoids were isolated from the pine tree bark Tested with Bate-Smith, Metcalf Method
ISOLATED COMPOUNDS
TERPENOIDS
1 2 2.19 grams (0.62%) of the product was obtained Lieberman-Burchard Test
ANTIMICROBIAL PROPERTY
POSITIVE CONTROL
MICROORGANISM Staphylococcus aureus Escherichia coli POSITIVE-CONTROL Oxacillin Ceftriaxone
NEGATIVE CONTROL
Dimethyl sulphoxide or DMSO, was used as the solvent for the crude extract and was subsequently used as the Negative control.
Count
Positive Control (mm) Negative Control (mm) Source of Variation SS Between Groups 1597.556 Within Groups 0.666667 Total 1598.222
SS 578 2 580
CRUDE EXTRACT
CRUDE EXTRACT
100mg/ml Plate 1 Plate 2 Plate 3 No growth No growth No growth 150mg/ml No growth No growth No growth
ANTIMICROBIAL PROPERTY OF ISOLATED COMPOUNDS Staphylococcus aureus is the only microorganism that showed susceptibility to the crude extract
Staphylococcus aureus
TANNIN EXTRACT
SS 484 2 486
df 1 2 3
MS 484 1
TANNIN EXTRACT
Staphylococcus aureus
FLAVONOIDS EXTRACT
ANOVA Source of Variation SS df Between Groups 210.25 Within Groups 2.5 Total 212.75
Staphylococcus aureus
TERPENOIDS EXTRACT
Count 12 2 35 2
df
MS 1 506.25 2 0.25 3
CONCLUSION
Crude extract of Pinus Kesiya has an antibacterial activity against Staphylococcus aureus, and has no antibacterial activity against Escherichia coli.
CONCLUSION
Terpenoids, flavonoids and tannins are present and isolated from the bark of Pinus kesiya.
Only tannin extract has an antibacterial activity against S. aureus. however the flavonoids and terpenoids did not show an antibacterial activity.
CONCLUSION
100 mg/ml was the lowest concentration of Pinus kesiya crude bark extract that showed antibacterial activity against S. aureus.
CONCLUSION
CONCLUSION
Staphylococcus aureus showed susceptibility to tannins and was resistant to flavonoids and terpenoids.
CONCLUSION
Crude extract is bacteriostatic and bactericidal against Staphylococcus aureus, however, Tannin extract is neither bactericidal nor bacteriostatic.
RECOMMENDATIONS
For further research studies
RECOMMENDATIONS
Further characterization and quantification of phytochemical compounds present in Pinus kesiya bark through molecular methods, HPLC.
RECOMMENDATIONS
Determination of the active compound that shows the greatest contribution in the antibacterial activity of the crude extract
THANK YOU!
In Vitro Antimicrobial Activity of Pinus kesiya bark extract against Staphylococcus aureus and Escherichia coli SECTION B
TH 25